|
Malaria interventions coverage
| Indicator |
1999 |
2000-2001 |
2004-2005 |
| % households with at least one mosquito net of any type |
30 |
37 |
46 |
| % households with at least one insecticide-treated net (ITN) |
1 |
- |
23 |
| % chidlren under five years of age sleeping under any type of mosquito net |
21 |
- |
31 |
| % children under five years of age sleeping under an insecticide-treated mosquito net (ITN) |
2 |
- |
16 |
| % children under five years of age with fever receiving any anti-malarial medicines |
53 |
- |
58 |
| % children under five years of age with fever receiving any anti-malarial medicines promptly (within 24 hours) |
- |
- |
51 |
| % children with fever receiving any anti-malarial medicines, by drug type |
- |
- |
58 |
| % women who received IPT (treatment with at least 2 doses of SP/Fansidar) during pregnancy |
- |
- |
22 |
| % pregnant women aged 15-49 years sleeping under an ITN |
- |
- |
16 |
Source: DHS 1999; NSO 2000/01; DHS 2004/0
- I. Epidemiological background
-
| Parasite (Plasmodium) types |
The main parasite is Plasmodium falciparum. |
| Main vector (mosquito) types |
An. Arabiensis, An. Funestus, An. Gambiae, An. Coustani, An. Merus, An. Nili, An. Paludis, An. Pharoensis |
| Total population |
38,291,219 (2007) |
| Population at risk |
38,291,219 (2007) |
| ~ 100% of the population lives in areas at risk of malaria |
| Pregnant women at risk of malaria |
1,645,573 (2007) |
| Children under five at risk of malaria |
7,031,077 ( 2007) |
| Number of reported clinical malaria / fever cases |
13,104,143 (2006) |
| Reported malaria episodes |
13,104,143 (2006) |
| Child under 5 malaria mortality |
53,320 ( 2005) |
| Infant mortality (per 1000) |
112 (2005) |
Source of the data: NMCP, DHS 2005
- II. Current Policy and Strategy
-
Coming soon
- III. Primary interventions
-
[+] Malaria OPD cases, malaria admitted cases, malaria deaths in health facilities
[+] Malaria in pregnancy
[+] Nets and ITNs Ownership
- IV. Challenges and Priority support needs (2008 - 2010)
-
Challenges
- Universal coverage including home treatment is a challenge
(Artemether/Alumefantrine, at 12-15 USD not affordable at private sector outlets which provide for 30-40% of malaria treatment service)
- No alternate drug to SP for IPT
- Women coming late for ANC
- Universal Access to Long Lasting Insecticide Treated Nets (3 nets/ household)
- At least 300 million USD needed to cover the whole population
- Funding: 5 yrs IRS Master Plan requires 70.4 million USD
- Human resource constraints at all levels
- Sustaining the momentum-global- funding
- Partnership building at country level
- Malaria parasite drug resistance
- Vector Insecticide resistance
- Behavioural change takes time
- Poverty
|
- V. Key RBM Partners in Rwanda
-
For questions, contact Ms Nadia Lasri, RBM Partnership facilitation
Dr James Banda, RBM Partnership facilitation Coordinator,
Dr Alex Mwita, National Malaria Control Programme Manager
|
Country action
Country info
Burundi
